Annual Financials for ICU Medical Inc.
Operating Activities
Fiscal year is January-December. All values USD millions. |
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Net Income before Extraordinaries |
68.64M | 28.79M | 101.04M | 86.87M | 103.14M | |
Net Income Growth |
- | -58.05% | 250.90% | -14.02% | 18.72% | |
Depreciation, Depletion & Amortization |
66.57M | 74.74M | 85.21M | 94.85M | 99.29M | |
Depreciation and Depletion |
51.57M | 58.14M | 67.51M | 71.65M | 75.49M | |
Amortization of Intangible Assets |
15M | 16.6M | 17.7M | 23.2M | 23.8M | |
Deferred Taxes & Investment Tax Credit |
- | - | - | - | - | |
Deferred Taxes |
- | - | - | - | - | |
Investment Tax Credit |
- | - | - | - | - | |
Other Funds |
(36.68M) | 82.09M | 27.31M | 58M | 50.07M | |
Funds from Operations |
98.54M | 185.62M | 213.55M | 239.72M | 252.5M | |
Extraordinaries |
- | - | - | - | - | |
Changes in Working Capital |
55.89M | (25.41M) | (111.64M) | (16.97M) | 15.04M | |
Receivables |
(149.84M) | 20.7M | (23.68M) | 78.05M | 13.76M | |
Accounts Payable |
46.65M | 23.27M | (2.7M) | (46.42M) | 2.35M | |
Other Assets/Liabilities |
(56.43M) | (18.05M) | (16.57M) | (38.42M) | (28.14M) | |
Net Operating Cash Flow |
154.42M | 160.22M | 101.92M | 222.75M | 267.54M | |
Net Operating Cash Flow Growth |
- | 3.75% | -36.39% | 118.56% | 20.11% | |
Net Operating Cash Flow / Sales |
11.95% | 11.44% | 8.05% | 17.53% | 20.32% | |
Investing Activities
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Capital Expenditures |
(79.68M) | (100.78M) | (106.04M) | (100.39M) | (81.17M) | |
Capital Expenditures (Fixed Assets) |
(74.48M) | (92.72M) | (97.31M) | (92.01M) | (68.54M) | |
Capital Expenditures (Other Assets) |
(5.2M) | (8.06M) | (8.73M) | (8.39M) | (12.63M) | |
Capital Expenditures Growth |
- | -26.48% | -5.22% | 5.33% | 19.15% | |
Capital Expenditures / Sales |
-6.16% | -7.20% | -8.37% | -7.90% | -6.17% | |
Net Assets from Acquisitions |
(162.45M) | (1.3M) | (76.13M) | - | (14.45M) | |
Sale of Fixed Assets & Businesses |
2,000 | 13.77M | 33,000 | 6.18M | 218,000 | |
Purchase/Sale of Investments |
(24.74M) | (15.06M) | 15.25M | (3.93M) | 4.72M | |
Purchase of Investments |
(24.74M) | (30.5M) | (26.04M) | (32.83M) | (13.28M) | |
Sale/Maturity of Investments |
- | 15.44M | 41.29M | 28.9M | 18M | |
Other Uses |
- | - | - | - | - | |
Other Sources |
- | - | - | - | - | |
Net Investing Cash Flow |
(266.87M) | (103.37M) | (166.89M) | (98.14M) | (90.69M) | |
Net Investing Cash Flow Growth |
- | 61.27% | -61.45% | 41.19% | 7.59% | |
Net Investing Cash Flow / Sales |
-20.65% | -7.38% | -13.18% | -7.72% | -6.89% | |
Financing Activities
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Cash Dividends Paid - Total |
- | - | - | - | - | |
Common Dividends |
- | - | - | - | - | |
Preferred Dividends |
- | - | - | - | - | |
Change in Capital Stock |
30.65M | 8.02M | (10.91M) | 317,000 | 1.04M | |
Repurchase of Common & Preferred Stk. |
(4.06M) | (6.25M) | (18.64M) | (12.88M) | (8.34M) | |
Sale of Common & Preferred Stock |
34.71M | 14.28M | 7.73M | 13.19M | 9.37M | |
Proceeds from Stock Options |
2.71M | - | - | - | - | |
Other Proceeds from Sale of Stock |
32M | 14.28M | 7.73M | 13.19M | 9.37M | |
Issuance/Reduction of Debt, Net |
(75M) | - | - | (357,000) | (607,000) | |
Change in Current Debt |
- | - | - | - | - | |
Change in Long-Term Debt |
(75M) | - | - | (357,000) | - | |
Issuance of Long-Term Debt |
- | - | - | - | - | |
Reduction in Long-Term Debt |
(75M) | - | - | (357,000) | (607,000) | |
Other Funds |
- | - | - | - | (17.3M) | |
Other Uses |
- | - | - | - | (17.3M) | |
Other Sources |
- | - | - | - | - | |
Net Financing Cash Flow |
(44.35M) | 8.02M | (10.91M) | (40,000) | (16.87M) | |
Net Financing Cash Flow Growth |
- | 118.09% | -235.95% | 99.63% | -42,075.00% | |
Net Financing Cash Flow / Sales |
-3.43% | 0.57% | -0.86% | 0.00% | -1.28% | |
Exchange Rate Effect |
1.79M | (10.16M) | (234,000) | 2.85M | (3.25M) | |
Miscellaneous Funds |
- | - | - | - | - | |
Net Change in Cash |
(155.01M) | 54.71M | (76.11M) | 127.43M | 156.73M | |
Free Cash Flow |
79.94M | 67.5M | 4.61M | 130.75M | 199M | |
Free Cash Flow Growth |
- | -15.57% | -93.18% | 2,738.62% | 52.20% | |
Free Cash Flow Yield |
- | - | - | - | 3.85% | NA |